Literature DB >> 31512269

Rifaximin for sickle cell disease.

Seah H Lim1,2, Dibyendu Dutta1,2, Judy Moore2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31512269     DOI: 10.1002/ajh.25637

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

Review 1.  L-glutamine for sickle cell disease: more than reducing redox.

Authors:  Firas Jafri; Gyuhee Seong; Tim Jang; Emanuela Cimpeanu; Maria Poplawska; Dibyendu Dutta; Seah H Lim
Journal:  Ann Hematol       Date:  2022-05-14       Impact factor: 4.030

Review 2.  Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice.

Authors:  Maroun Bou Zerdan; Stephanie Niforatos; Sandy Nasr; Dayana Nasr; Mulham Ombada; Savio John; Dibyendu Dutta; Seah H Lim
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

3.  How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia.

Authors:  Mariana Delgadinho; Catarina Ginete; Brígida Santos; Carolina Fernandes; Carina Silva; Armandina Miranda; Jocelyne Neto de Vasconcelos; Miguel Brito
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.